Investor Overview

Webcast ImageWebcast
Selecta/Spark License Agreement Conference Call (Replay)
Dec 05, 2016 at 9:00 a.m. ET
Selecta/Spark License Agreement Conference Call
Monday, December 5, 2016 9:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Selecta Biosciences Phase 1 Data Conference Call (Live)
Dec 08, 2016 at 8:30 a.m. ET
Selecta Biosciences Phase 1 Data Conference Call
Thursday, December 8, 2016 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Selecta Biosciences Inc at 28th Annual Piper Jaffray Healthcare Conference (Replay)
Nov 30, 2016 at 2:00 p.m. ET
Selecta Biosciences Inc at 28th Annual Piper Jaffray Healthcare Conference
Wednesday, November 30, 2016 2:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Selecta Biosciences is a clinical-stage biopharmaceutical company developing targeted immunotherapies and vaccines that are designed to modulate immune responses to treat and prevent disease. Selecta’s proprietary Synthetic Vaccine Particle (SVP™) platform has the potential to create a new paradigm in immunology and may enable a novel approach for selectively targeting the immune system to effectively and safely treat and prevent rare and serious dis... View more »

Recent News
View all press releases »
Download DocumentationNov 14, 2016
November Investor Presentation
Download DocumentationAug 04, 2016
BioWorld - Tolerizing nanoparticles could broaden the scope of biologics
Upcoming Events
Dec 08, 2016 8:30 a.m. ET
Selecta Biosciences Phase 1 Data Conference Call
remind me days before the event
Enter your e-mail address 
View all events »
Stock Quote
NASDAQ GS :  SELB (Common Stock)
$23.95
0.00 (0.00%)
Stock chart for: SELB.O.  Currently trading at $23.95 with a 52 week high of $28.00 and a 52 week low of $10.26.
Data as of Dec 06, 2016 4:00 p.m. ET
Minimum 15 minute delay
Refresh quote
IR Contact
Jason Fredette
Selecta Biosciences
Phone: 1 617 231 8078
E-mail: JFredette@selectabio.com

Data provided by Nasdaq. Minimum 15 minutes delayed.
Back to Top